Publish with Us

Cancer Immunology Connect

Eyad Elkord
Editor-in-Chief

Eyad Elkord
Editor-in-Chief

View Profile

Cancer Immunology Connect is a peer-reviewed, open-access journal focused on understanding the complex interactions between cancer cells and the immune system. It publishes innovative research on tumor immunology, cancer immunotherapy, and translational research to advance the fight against cancer through immunological approaches. The journal is available both in print and online, ensuring broad accessibility and dissemination of cutting-edge research to the global scientific community.

Volumes 1
Articles 4
Volume: 1, 2024

Recent Articles

Review Article

Published: 10 Feb 2025

Soluble biomarkers as predictors of response to immunotherapy in Non-Small Cell Lung cancer (NSCLC)-insights from the tumor microenvironment perspective

Volume 1

Lung cancer is the major cause of mortality worldwide with non-small cell lung cancer (NSCLC) contributing to 85% of the cases. FDA approved immune checkpoint inhibitors (ICI), anti-PD-1 and anti-PD-L1 are widely used as a standard treatment. However, the response rate is limited and is observed in only 20-40% of the patients. Therefore, predictive and prognostic biomarkers are needed to help differentiate responders from non-responders, enabling a better understanding of..

Mini-Review

Published: 24 Jan 2025

CRISPR-Cas9 Is Revolutionizing AML Treatment As A Novel Therapy

Volume 1

Review Article

Published: 20 Dec 2024

Chronic Myelomonocytic Leukemia Relapse After Transplant

Volume 1

Relapse of Chronic Myelomonocytic Leukemia after allogeneic hematopoietic stem cell transplantation remains a significant challenge, with relapse rates reaching up to 50%, contributing to poor survival outcomes. This paper explores the factors influencing relapse, including disease biology and persistence of residual disease. Current, post- transplant strategies, such as maintenance therapies and immunomodulatory treatments, are discussed for their potential to reduce the likelihood of relapse. It also highlights emerging therapies, such..

Review Article

Published: 21 Oct 2024

Neoantigen-Based Cancer Vaccines: Current Innovations, Challenges and Future Directions in Personalized Immunotherapy

Volume 1